The shares of this small-cap company have gained over 24.66 per cent in a month and delivered more than 644.06 per cent returns over a period of one year. 

Another interesting point is that it’s not very usual these days to see pharma stock jumping 8-9 per cent but on Tuesday, Lupin broke this jinx as it soared nearly 9 per cent. Certainly, this might have brought a million-dollar smile to the faces of Lupin investors.